Picard Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	0.12	7.45	0.1	0.24	0.15
Cash & Short-Term Investments	0.12	7.45	0.1	0.24	0.15
Cash Growth	-82.41%	7661.46%	-60.66%	60.53%	-
Accounts Receivable	0.6	0.62	0.51	0.63	0.88
Inventory	7.45	7.3	8.12	6.89	7.33
Other Current Assets	1.35	5.35	1.07	1	3.76
Total Current Assets	9.51	20.73	9.79	8.76	12.12
Net Property, Plant & Equipment	0.61	0.7	1.1	1.31	1.93
Other Intangible Assets	0.49	0.51	0.6	0.68	0.77
Goodwill	0.62	0.62	0.62	0.62	0.62
Total Assets	11.22	22.55	12.11	11.37	15.44
Accounts Payable	2.71	2.08	5.29	3.08	1.39
Accrued Expenses	1.98	1.86	2.86	1.76	0.72
Short-Term Debt	2.86	6.45	5.15	4.06	0.62
Current Portion of Long-Term Debt	-	-	14.83	-	-
Current Portion of Leases	0.41	0.46	0.43	0.31	0.27
Other Current Liabilities	4.7	7.84	6.76	-	-
Total Current Liabilities	12.66	18.7	35.33	9.21	3
Long-Term Debt	-	-	-	4.28	-
Long-Term Leases	0.01	0.06	0.52	0.76	1.07
Other Long-Term Liabilities	-	-	-	0.67	-
Total Long-Term Liabilities	0.01	0.06	0.52	5.71	1.07
Total Liabilities	12.67	18.76	35.84	14.93	4.07
Common Stock	0.01	0.01	0	0	-
Additional Paid-in Capital	82.76	80.4	5.56	4.68	3.92
Accumulated Other Comprehensive Income	0.25	0.23	0.28	0.29	0.4
Retained Earnings	-84.46	-76.84	-49.84	-28.79	-13.22
Total Common Shareholders' Equity	-1.45	3.79	-44	-23.82	-8.9
Minority Interest	-	-	20.27	20.27	20.27
Shareholders' Equity	-1.45	3.79	-23.74	-3.55	11.37
Total Liabilities & Equity	11.22	22.55	12.11	11.37	15.44
Total Debt	3.27	6.98	20.93	9.41	1.96
Net Cash (Debt)	-3.15	0.48	-20.83	-9.17	-1.81
Net Cash Per Share	-0.06	0.01	-2.62	-1.15	-0.32
Book Value	-1.45	3.79	-44	-23.82	-8.9
Book Value Per Share	-0.03	0.10	-5.54	-3.00	-1.59
Tangible Book Value	-2.55	2.67	-45.21	-25.12	-10.28
Tangible Book Value Per Share	-0.05	0.07	-5.69	-3.16	-1.84

SEC Filings: 10-K · 10-Q